CORONARY ARTERY ECTASIA

Clinical trials for CORONARY ARTERY ECTASIA explained in plain language.

Never miss a new study

Get alerted when new CORONARY ARTERY ECTASIA trials appear

Sign up with your email to follow new studies for CORONARY ARTERY ECTASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Heart attack patients with rare artery condition may benefit from new blood thinner combo

Disease control Recruiting now

This study tests whether adding a blood thinner (rivaroxaban) to a single antiplatelet drug (clopidogrel) works better than the standard two antiplatelet drugs (aspirin plus clopidogrel) for people with acute coronary syndrome and a condition called coronary artery ectasia, where…

Matched conditions: CORONARY ARTERY ECTASIA

Phase: PHASE4 • Sponsor: Instituto Nacional de Cardiologia Ignacio Chavez • Aim: Disease control

Last updated May 07, 2026 18:41 UTC

CORONARY ARTERY ECTASIA

Get alerted when new CORONARY ARTERY ECTASIA trials appear

Heart attack patients with rare artery condition may benefit from new blood thinner combo